SEARCH

SEARCH BY CITATION

References

  • Abraham M. H. and Platts J. A. (2001) Hydrogen bond structural group constants. J. Org. Chem. 66, 34843491.
  • Allen J. W., Ivanova S. A., Fan L., Espey M. G., Basile A. S. and Faden A. I. (1999) Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J. Pharmacol. Exp. Ther. 290, 112120.
  • Bertrand H.-O., Bessis A.-S., Pin J.-P. and Archer A. C. (2002) Common and selective molecular determinants involved in metabotropic glutamate receptor agonist activity. J. Med. Chem. 45, 31713183.
  • Bessis A.-S., Rondard P., Gaven F., Brabet I., Triballeau N., Prezeau L., Acher F. and Pin J.-P. (2002) Closure of the Venus flytrap module of mGlu8 receptor and the activation process: insights from mutations converting antagonists into agonists. Proc. Natl Acad. Sci. 99, 1109711102.
  • Bond A. et al. (2000) Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo. J. Pharmacol. Exp. Ther. 294, 800809.
  • Brabet I., Parmentier M.-L., De Colle C., Bockaert J., Archer F. and Pin J.-P. (1998) Comparative effect of L-CCG-I, DCG-IV, and γ-carboxy-l-glutamate on all cloned metabotropic glutamate receptors subtypes. Neuropharmacology 37, 10431051.
  • Bräuner-Osborne H., Egebjerg J., Nielsen E. Ø., Madsen U. and Krogsgaard-Larsen P. (2000) Ligands for glutamate receptors: design and therapeutic prospects. J. Med. Chem. 43, 26092645.
  • Breysse N., Baunez C., Spooren W., Gaspirini F. and Amalric M. (2002) Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. J. Neurosci. 22, 56695678.
  • Bruno V., Battaglia G., Copani A., Giffard R. G., Raciti G., Raffaele R., Shinozaki H. and Nicoletti F. (1995) Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 7, 19061913.
  • Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F. and Nicoletti F. (1998) Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β. J. Neurosci. 18, 95949600.
  • Cartmell J., Adam G., Chabox S., Henningsen R., Kemp J. A., Klingelschmidt A., Metzler V., Monsma F., Schaffhauser H., Wichmann J. and Mutel V. (1998) Characterization of [3H]-(2S,2′R,3′R)-2-(2′,3′-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. Br. J. Pharmacol. 123, 497504.
  • Conn P. J. and Pin J.-P. (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205237.
  • Dawson L., Chadha A., Megalou M. and Duty S. (2000) The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat. Br. J. Pharmacol. 129, 541546.
  • Ferraguti F., Corti C., Valerio E., Mion S. and Xuereb J. (2001) Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5. Exp. Brain Res. 137, 111.
  • Hampson D. R., Huang X.-P., Pekhletski R., Peltekova V., Hornby G., Thomsen C. and Thogersen H. (1999) Probing the ligand-binding domain of the mGluR4 subtype of metabotropic glutamate receptor. J. Biol. Chem. 274, 3348833495.
  • Han G. and Hampson D. R. (1999) Ligand binding to the amino terminal domain of the mGluR4 subtype of metabotropic glutamate receptor. J. Biol. Chem. 274, 1000810013.
  • Hayashi Y., Momiyama A., Takahashi T., Ohishi H., Ogawa-Meguro R., Shigemoto R., Mizuno N. and Nakanishi S. (1993) Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb. Nature 366, 687690.
  • Helton D. A., Tizzano J. P., Monn J. A., Schoepp D. D. and Kallman M. J. (1998) Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 284, 651660.
  • Higgins D., Thompson J., Gibson T., Thompson J. D., Higgins D. G. and Gibson T. J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 46734680.
  • Ishida M., Saitoh T., Shimamoto K., Ofune Y. and Shinozaki H. (1993) A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. Br. J. Pharmacol. 109, 11691177.
  • Jensen A. A., Sheppard P. O., O'Hara P. J., Krogsgaard-Larsen P. and Bräuner-Osborne H. (2000) The role of Arg 78 in the metabotropic glutamate receptor mGlu1 for agonist binding and selectivity. Eur. J. Pharmacol. 397, 247253.
  • Jullian N., Brabet I., Pin J.-P. and Acher F. C. (1999) Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation. J. Med. Chem. 42, 15461555.
  • Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H. and Morikawa K. (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971977.
  • Macchiarulo A., Costantino G., Sbaglia R., Aiello S., Meniconi M. and Pellicciari R. (2003) The role of electrostatic interaction in the molecular recognition of selective agonists to metabotropic glutamate receptors. Proteins 50, 609619.
  • Malherbe P., Knoflach F., Broger C., Ohresser S., Kratzeisen C., Adam G., Stadler H., Kemp J. A. and Mutel V. (2001) Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor. Mol. Pharmacol. 60, 944954.
  • Moghaddam B. and Adams B. W. (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 13491352.
  • Monn J. A. et al. (1997) Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 40, 528537.
  • Nakazato A., Kumagai T., Sakagami K., Yoshikawa R., Suzuki Y., Chaki S., Ito H., Taguchi T., Nakanishi S. and Okuyama S. (2000) Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists. J. Med. Chem. 43, 48934909.
  • Naples M. A. and Hampson D. R. (2001) Pharmacological profiles of the metabotropic glutamate receptor ligands [3H]L-AP4 and [3H]CPPG. Neuropharmacology 40, 170177.
  • Okamoto T., Sekiyama N., Otsu M., Shimada Y., Sato A., Nakanishi S. and Jingami H. (1998) Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 273, 1308913096.
  • Parmentier M. L., Galvez T., Acher F., Peyre B., Pellicciari R., Grau Y., Bockaert J. and Pin J.-P. (2000) Conservation of the ligand recognition site of metabotropic glutamate receptors during evolution. Neuropharmacology 39, 11191131.
  • Parmentier M. L., Prezeau L., Bockaert J. and Pin J.-P. (2002) A model for the functioning of family 3 GPCRs. Trends Pharmacol. Sci. 23, 268274.
  • Peltekova V., Han G., Soleymanlou N. and Hampson D. R. (2000) Constraints on proper folding of the amino terminal domains of group III metabotropic glutamate receptors. Mol. Brain Res. 76, 180190.
  • Petralia R. S., Wang Y.-X., Niedzielski A. S. and Wenthold R. J. (1996) The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71, 949976.
  • Pin J.-P., De Colle C., Bessis A.-S. and Archer F. (1999) New perspectives for the development of selective metabotropic glutamate receptor ligands. Eur. J. Pharmcol. 375, 277294.
  • Ramachandran G. N., Ramakrishnan C. and Sasisekharan V. (1963) Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 7, 9599.
  • Rosemond E., Peltekova V., Naples M., Thogersen H. and Hampson D. R. (2002) Molecular determinants of high affinity binding to group III metabotropic glutamate receptors. J. Biol. Chem. 277, 73337340.
  • Sato T., Shimada Y., Nagasawa N., Nakanishi S. and Jingami H. (2003) Amino acid mutagenesis of the ligand binding pocket and the dimer interface of the metabotropic glutamate receptor 1: identification of crucial residues for setting the activated state. J. Biol. Chem. 278, 43144321.
  • Schaffhauser H., Richards J. G., Cartmell J., Chaboz S., Kemp J. A., Klingelschmidt A., Messer J., Stadler H., Woltering T. and Mutel V. (1998) In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain. Mol. Pharmacol. 53, 228233.
  • Schoepp D. D., Johnson B. G., Wright R. A., Salhoff C. R., Mayne N. G., Wu S., Cockerman S. L., Burnett J. P., Belegaje R. and Bleakman D. (1997) LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 36, 111.
  • Schoepp D. D., Jane D. E. and Monn J. A. (1999) Pharmacological agents at subtypes of metabotropic glutamate receptors. Neuropharmacology 38, 14311476.
  • Selkirk J. V., Challiss R. A. J., Rhodes A. and McIlhinney (2002) Characterization of an N-terminal domain of the human metabotropic glutamate receptor produced by a mammalian cell line. J. Neurochem. 80, 346353.
  • Tamura Y., Nomura S., Mizuno N. and Shigemoto R. (2001) Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 106, 481503.
  • Tanabe Y., Masu M., Ishii T., Shigemoto R. and Nakaniski S. (1992) A family of metabotropic glutamate receptors. Neuron 8, 169179.
  • Tatarczynska E., Klodzinska A., Kroczka B., Chojnacka-Wojcik E. and Pilc A. (2001) The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intra-hippocampal administration. Psychopharmacology 158, 9499.
  • Tsuchiya D., Kunishima N., Kamiya N., Jingami H. and Morikawa K. (2002) Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd+. Proc. Natl Acad. Sci. USA 99, 26602665.